Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...

AI could review data sets to assist clinical scientists ...

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Here’s how drug developers can best approach interactions with the agency following last year’s seismic changes to its leadership, workforce and policies.

Infrastructure and location have helped make Holly Springs a future hub for obesity drug production, with Amgen and Roche ...

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Provincial government efforts to get people help with homelessness and substance-use challenges are running into opposition ...

The Maryland Street project showed the world a better way but at home their message was not heeded ...

Purdue University drug discovery scholar and faculty member, entrepreneur, and philanthropist Philip Low, whose life’s work turned laboratory discoveries into therapies ...

The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency.

One Florida sheriff’s office is giving new meaning to the phrase "protect and serve" — one treat at a time. The Orange County Sheriff’s Office has turned $90,000 seized from convicted drug dealers ...